SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 50 filers reported holding SIERRA ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $59,000 | -11.9% | 170,912 | +42.6% | 0.01% | +50.0% |
| Q2 2019 | $67,000 | +109.4% | 119,841 | +542.8% | 0.00% | +100.0% |
| Q1 2019 | $32,000 | +39.1% | 18,645 | +35.4% | 0.00% | +100.0% |
| Q3 2018 | $23,000 | -85.3% | 13,768 | -73.9% | 0.00% | -85.7% |
| Q2 2018 | $156,000 | +108.0% | 52,694 | +45.8% | 0.01% | +75.0% |
| Q1 2018 | $75,000 | +66.7% | 36,129 | +196.5% | 0.00% | +100.0% |
| Q4 2017 | $45,000 | – | 12,186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 8,112,121 | $10,708,000 | 2.76% |
| New Leaf Venture Partners, L.L.C. | 5,020,446 | $6,627,000 | 1.82% |
| Prosight Management, LP | 2,553,943 | $3,371,000 | 1.74% |
| Abingworth LLP | 1,444,445 | $1,892,000 | 1.72% |
| Broadfin Capital, LLC | 4,880,327 | $6,442,000 | 0.85% |
| MANGROVE PARTNERS IM, LLC | 3,688,609 | $4,869,000 | 0.65% |
| Vivo Capital, LLC | 2,438,270 | $3,219,000 | 0.41% |
| PA Capital LLC | 138,752 | $183,000 | 0.19% |
| 683 Capital Management, LLC | 2,173,620 | $2,869,000 | 0.17% |
| ARMISTICE CAPITAL, LLC | 1,600,000 | $2,112,000 | 0.16% |